Overview

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To explore the anti-impulsive and anti-aggressive properties of brexpiprazole in a naturalistic setting of depressed patients with irritability.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Antidepressive Agents
Brexpiprazole